Hinova Pharmaceuticals (SHSE:688302) Total Stockholders Equity : ¥1,231.57 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Hinova Pharmaceuticals Total Stockholders Equity?

Hinova Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ¥1,231.57 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hinova Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2024 was ¥12.44. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hinova Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.01.

Hinova Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for Hinova Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hinova Pharmaceuticals Total Stockholders Equity Chart

Hinova Pharmaceuticals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

-36.17

986.15

788.76

1,585.39

1,367.09

Hinova Pharmaceuticals Quarterly Data
	Dec18	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial														1,404.14	1,367.09	1,326.10	1,279.13	1,231.57

Hinova Pharmaceuticals (SHSE:688302) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hinova Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1231.572	-	0)	/	99.0156
	=	12.44

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hinova Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.378	+	6.565)	/	1231.572
	=	0.01

Hinova Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hinova Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hinova Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hinova Pharmaceuticals Inc (SHSE:688302) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Keyuan South Road, No. 2 and 3, 4th Floor, Building 1, Rongyao Building, High-tech Zone, Sichuan Province, Chengdu, CHN, 610041

Website

http://www.hinovapharma.com

Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.

Hinova Pharmaceuticals Headlines

No Headlines